Chlorpheniramine maleate is a well-known antihistamine that has been in use for several decades. It is commonly found under various trade names, such as Chlor-Trimeton, Aller-Chlor, and Piriton. This drug is primarily used to treat symptoms of allergic conditions, including
hay fever,
rhinitis,
urticaria, and other forms of
allergy. It targets
histamine H1 receptors in the body, thereby reducing the effects of
histamine, a substance that the body produces during an allergic reaction. The research and development of chlorpheniramine maleate have been extensive, involving numerous pharmaceutical companies and research institutions worldwide. It is classified as a first-generation antihistamine, which means it can cross the blood-brain barrier and cause sedation—a characteristic shared with other first-generation antihistamines like
diphenhydramine and
promethazine. Despite its sedative properties, chlorpheniramine maleate remains a popular choice for the management of allergic symptoms due to its efficacy and relatively well-understood safety profile.
Chlorpheniramine maleate works by inhibiting the action of histamine at the H1 receptor sites. Histamine is a naturally occurring compound in the body that plays a significant role in allergic reactions. When the body comes into contact with an allergen, such as pollen, dust mites, or pet dander, it releases histamine from mast cells and basophils. This release triggers a cascade of symptoms, including
itching,
swelling,
redness, and increased mucus production. Chlorpheniramine maleate binds to the
H1 receptors, thereby blocking histamine from exerting its effects. This action helps to alleviate the symptoms associated with allergic reactions. Additionally, chlorpheniramine maleate has anticholinergic properties, which means it can block the action of acetylcholine, a neurotransmitter involved in the regulation of various bodily functions, including mucus secretion and muscle contraction. The anticholinergic effects contribute to the drug's efficacy in reducing nasal and bronchial secretions, making it particularly useful in conditions like
allergic rhinitis.
Chlorpheniramine maleate is available in various forms, including tablets, capsules, syrups, and injectable solutions. The method of administration largely depends on the patient's age, the severity of the symptoms, and the form of the medication. For adults and children over 12 years old, the typical dosage is 4 mg every 4 to 6 hours, not exceeding 24 mg in 24 hours. For children aged 6 to 12 years, the standard dose is 2 mg every 4 to 6 hours, with a maximum of 12 mg in 24 hours. The drug is also available in extended-release formulations, which are taken less frequently, typically once or twice daily. Chlorpheniramine maleate usually starts to work within 30 minutes to an hour after oral administration, with peak effects occurring within 2 to 3 hours. The duration of action is generally 4 to 6 hours for immediate-release forms and up to 12 hours for extended-release forms. It is essential to follow the dosing instructions provided by a healthcare professional or as indicated on the product label to avoid potential side effects and ensure optimal efficacy.
Despite its effectiveness, chlorpheniramine maleate is associated with several side effects. The most common adverse effects include
drowsiness,
dizziness,
dry mouth,
constipation, blurred vision, and
urinary retention. These side effects are primarily due to the drug's anticholinergic properties. Because of the sedative effects, it is advised not to operate heavy machinery or drive while taking this medication. In some cases, patients may experience more severe side effects, such as
confusion,
hallucinations, severe dizziness, or an
irregular heartbeat. If any of these symptoms occur, it is crucial to seek medical attention immediately. Chlorpheniramine maleate is contraindicated in individuals with hypersensitivity to the drug or any of its components. It should also be used with caution in patients with
glaucoma,
peptic ulcers,
prostatic hypertrophy,
bladder neck obstruction, or
respiratory conditions like
asthma and
chronic obstructive pulmonary disease (COPD). Pregnant and breastfeeding women should consult their healthcare providers before using chlorpheniramine maleate, as its safety during pregnancy and lactation has not been fully established.
Several other drugs can interact with chlorpheniramine maleate, potentially altering its effectiveness or increasing the risk of adverse effects. For instance, the concurrent use of other central nervous system depressants, such as alcohol, sedatives, hypnotics, and tranquilizers, can enhance the sedative effects of chlorpheniramine maleate, leading to increased drowsiness and
impaired cognitive function.
Monoamine oxidase inhibitors (MAOIs), which are used to treat
depression, can prolong and intensify the anticholinergic effects of chlorpheniramine maleate. Therefore, it is generally recommended to avoid using chlorpheniramine maleate while taking MAOIs or within two weeks of discontinuing them. Additionally, other medications with anticholinergic effects, such as certain antidepressants, antipsychotics, and medications used to treat
Parkinson's disease, can exacerbate the anticholinergic side effects of chlorpheniramine maleate. Patients should always inform their healthcare providers about all the medications they are currently taking, including over-the-counter drugs and herbal supplements, to avoid potential drug interactions. This information helps healthcare providers make appropriate recommendations and adjustments to the treatment plan to ensure patient safety and optimal therapeutic outcomes.
In conclusion, chlorpheniramine maleate is a widely used first-generation antihistamine effective in alleviating the symptoms of various allergic conditions. Its ability to block histamine H1 receptors and exert anticholinergic effects makes it a valuable option for managing allergic rhinitis, urticaria, and other allergic reactions. However, it is essential to use this medication as directed and be aware of its potential side effects and contraindications. By understanding the interactions with other drugs, patients and healthcare providers can work together to ensure the safe and effective use of chlorpheniramine maleate in the management of allergic symptoms.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!